STAT5B-Related Growth Hormone Insensitivity: A Patient Guide

Receiving a diagnosis of STAT5B deficiency—more accurately known as STAT5B-related growth hormone insensitivity with immune dysregulation, and historically referred to as Laron syndrome with immunodeficiency—brings a unique set of challenges that span two different systems of the body. While this guide is written primarily for parents, as the condition is almost always diagnosed in childhood, STAT5B deficiency is a lifelong condition that requires care from childhood through adulthood.

In most children, the STAT5B protein acts as a critical internal messenger that helps the body respond to growth hormone and maintains the delicate balance of the immune system ^[1]. When this messenger is missing or not functioning correctly, impaired STAT5B signaling reduces the production of IGF-I (a key growth factor) and causes the immune system to lose its ability to properly regulate itself ^[2]. This dual nature means that patients can face both severe growth failure and a range of immune-related symptoms, such as chronic eczema, frequent infections, or autoimmune issues ^[3].

Because the condition involves multiple organ systems, the most important aspect of care is a coordinated, multidisciplinary medical team. Families typically work closely with a pediatric endocrinologist to manage growth, a clinical immunologist to monitor the immune system, and a pulmonologist to protect lung health if respiratory symptoms arise ^[4]. This collaboration ensures that every aspect of the patient’s health is monitored simultaneously, as treatments for growth can sometimes impact other systems, and immune health can directly influence overall development ^[5].

Living with this condition requires a focus on both daily treatment and long-term vigilance. To address growth failure, a specialist may consider a medication called mecasermin (rhIGF-1), while the immune system is supported through tailored, individualized strategies to prevent and manage infections ^[6]. Two critical areas that require ongoing attention are the risk of hypoglycemia (low blood sugar), which can occur as a side effect of growth treatment, and the potential for chronic lung disease, particularly in certain genetic forms of the condition ^[7][8]. Staying alert to these complications allows for early intervention and better long-term health management.

While the diagnosis is ultra-rare and the medical landscape can feel complex, having a named condition provides a roadmap for the future. Understanding the specific genetic and biological drivers of your child’s symptoms allows your care team to move away from general “short stature” or “immune” protocols and toward a personalized plan ^[9]. With proactive monitoring, an individualized emergency plan, and a dedicated team, families can focus on supporting their child’s growth and well-being while navigating the unique path of this multisystem disorder ^[10].